http://www.imim.cat/noticies Programa de recerca: Càncer http://www.imim.cat/noticies/view.php?ID=840 <p>A study in mice by the Hospital del Mar Research Institute and the IIBB-CSIC, published in Science Advances, identifies inhibition of the PARP2 protein as a therapeutic target for treating pancreatic cancer, the third leading cause of cancer death worldwide.&nbsp;The study analyses the role of this protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune system.&nbsp;Specifically blocking this protein may be a useful strategy for treating a large number of patients with pancreatic cancer and could even be applicable to other types of tumours.</p> 18/06/2026